Skip to main content
Log in

Multiple sclerosis news from AAN

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Clifford DB, DeLuca A, Simpson D, Arendt G, Giovannoni G, Nath A.Progressive Multifocal Leukoencephalopathy with Natalizumab Treatment of Multiple Sclerosis. 62nd Annual Meeting of the American Academy of Neurology: abstr. PL01.003, 10 Apr 2010. Available from: URL: http://www.abstracts2view.com/aan

  2. Frenay CL, Debouverie M, Brassat D, Vermersch P, Defer G, de Seze J, Clavelou P, Heinzlef O, Rumbach L, Wiertlevski S, Tourniaire P, Berthier F.Cancer Risk among Patients with Multiple Sclerosis during the Treatment Era: The CARIMS Study Update. 62nd Annual Meeting of the American Academy of Neurology: abstr. P06.135, 10 Apr 2010. Available from: URL: http://www.abstracts2view.com/aan

  3. Savettieri G, Aridon P, D'Amelio M, Mazzola MA, Realmuto S, Zummo L, Salemi G, Ragonese P.Frequency of mitoxantrone related heart involvement in patients affected by multiple sclerosis. 62nd Annual Meeting of the American Academy of Neurology: abstr. P06.140, 10 Apr 2010. Available from: URL: http://www.abstracts2view.com/aan

  4. Ionete C, Ebuh V, Singh A, Kane K, Lavallee J, Riskind P, Zawacki J.Central Demyelination Complicating the Use of Anti-TNF? in the Treatment of Inflammatory Bowel Disease(IBD): A Retrospective Study. 62nd Annual Meeting of the American Academy of Neurology: abstr. P06.166, 10 Apr 2010. Available from: URL: http://www.abstracts2view.com/aan

  5. Rocher F, Laffon M, Cohen M, Frenay CL.Hypereosinophilia with natalizumab. 62nd Annual Meeting of the American Academy of Neurology: abstr. P04.194, 10 Apr 2010. Available from: URL: http://www.abstracts2view.com/aan

  6. Hutton GJ, Avila M, Prieto PG, Avila J, Rivera VM.Multiple Sclerosis and Other CNS Demyelination after Treatment with Tumor Necrosis Factor alpha Blockers. 62nd Annual Meeting of the American Academy of Neurology: abstr. P04.215, 10 Apr 2010. Available from: URL: http://www.abstracts2view.com/aan

  7. Al-Sabbagh A, Dawson D, Bennett R, Dangond F.Acute leukemia in multiple sclerosis patients treated with mitoxantrone in the postmarketing setting: The EMD Serono experience. 62nd Annual Meeting of the American Academy of Neurology: abstr. P01.170, 10 Apr 2010. Available from: URL: http://www.abstracts2view.com/aan

  8. Dangond F, Dawson D, Beagan J, Bock D, Chang P, Yang Y, Bennett R, Al-Sabbagh A.Cardiovascular adverse events with mitoxantrone: Results from the registry to evaluate novantrone effects in worsening multiple sclerosis (RENEW) study. 62nd Annual Meeting of the American Academy of Neurology: abstr. P01.171, 10 Apr 2010. Available from: URL: http://www.abstracts2view.com/aan

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Multiple sclerosis news from AAN. React. Wkly. 1300, 3–4 (2010). https://doi.org/10.2165/00128415-201013000-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013000-00006

Keywords

Navigation